BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23820276)

  • 1. Novel thrombosis risk index as predictor of left ventricular assist device thrombosis.
    Trivedi JR; Sobieski MA; Schwartz S; Williams ML; Slaughter MS
    ASAIO J; 2013; 59(4):380-3. PubMed ID: 23820276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.
    Uriel N; Han J; Morrison KA; Nahumi N; Yuzefpolskaya M; Garan AR; Duong J; Colombo PC; Takayama H; Thomas S; Naka Y; Jorde UP
    J Heart Lung Transplant; 2014 Jan; 33(1):51-9. PubMed ID: 24290832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
    Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes.
    Ravichandran AK; Parker J; Novak E; Joseph SM; Schilling JD; Ewald GA; Silvestry S
    J Heart Lung Transplant; 2014 Jan; 33(1):44-50. PubMed ID: 24418733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
    Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
    J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic prediction of left ventricular assist device pump thrombosis based on lactate dehydrogenase trends.
    Hurst TE; Xanthopoulos A; Ehrlinger J; Rajeswaran J; Pande A; Thuita L; Smedira NG; Moazami N; Blackstone EH; Starling RC
    ESC Heart Fail; 2019 Oct; 6(5):1005-1014. PubMed ID: 31318170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients.
    Whitson BA; Eckman P; Kamdar F; Lacey A; Shumway SJ; Liao KK; John R
    Ann Thorac Surg; 2014 Jun; 97(6):2097-103. PubMed ID: 24775803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-Type Natriuretic Peptide Levels Predict Ventricular Arrhythmia Post Left Ventricular Assist Device Implantation.
    Hellman Y; Malik AS; Lin H; Shen C; Wang IW; Wozniak TC; Hashmi ZA; Pickrell J; Jani M; Caccamo MA; Gradus-Pizlo I; Hadi A
    Artif Organs; 2015 Dec; 39(12):1051-5. PubMed ID: 25864448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected abrupt increase in left ventricular assist device thrombosis.
    Starling RC; Moazami N; Silvestry SC; Ewald G; Rogers JG; Milano CA; Rame JE; Acker MA; Blackstone EH; Ehrlinger J; Thuita L; Mountis MM; Soltesz EG; Lytle BW; Smedira NG
    N Engl J Med; 2014 Jan; 370(1):33-40. PubMed ID: 24283197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support.
    Shah P; Mehta VM; Cowger JA; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):102-4. PubMed ID: 23968811
    [No Abstract]   [Full Text] [Related]  

  • 11. B-type natriuretic peptide levels and continuous-flow left ventricular assist devices.
    Sareyyupoglu B; Boilson BA; Durham LA; McGregor CG; Daly RC; Redfield MM; Edwards BS; Frantz RP; Pereira NL; Park SJ
    ASAIO J; 2010; 56(6):527-31. PubMed ID: 21245799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic markers better predict left ventricular assist device thrombosis than echocardiographic or pump parameters.
    Bartoli CR; Ghotra AS; Pachika AR; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2014 Aug; 62(5):414-8. PubMed ID: 24995532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices.
    Gavalas MV; Breskin A; Yuzefpolskaya M; Eisenberger A; Castagna F; Demmer RT; Flannery M; Garan AR; Takeda K; Takayama H; Naka Y; Topkara VK; Colombo PC
    J Heart Lung Transplant; 2017 Jan; 36(1):59-63. PubMed ID: 27773451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of LDH isoenzymes in hemolysis and continuous-flow left ventricular assist device-induced thrombosis.
    Gordon JS; Wood CT; Luc JGY; Watson RA; Maynes EJ; Choi JH; Morris RJ; Massey HT; Throckmorton AL; Tchantchaleishvili V
    Artif Organs; 2020 Mar; 44(3):231-238. PubMed ID: 31494952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular dimension decrement index early after axial flow assist device implantation: A novel risk marker for late pump thrombosis.
    Joyce E; Stewart GC; Hickey M; Coakley L; Rivero JM; Gosev I; Givertz MM; Couper GS; Mehra MR
    J Heart Lung Transplant; 2015 Dec; 34(12):1561-9. PubMed ID: 26508725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
    Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA
    J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Risk Factor Analysis for Gastrointestinal Bleeding and Pump Thrombosis in Left Ventricular Assist Device Recipients.
    Lopilato AC; Doligalski CT; Caldeira C
    Artif Organs; 2015 Nov; 39(11):939-44. PubMed ID: 25912789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.